Can ulcerative colitis be treated with azithromycin (Zithromax)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2025 • View editorial policy

From the Guidelines

Azithromycin is not recommended for treating ulcerative colitis due to the lack of strong evidence supporting its efficacy and the potential risks of disrupting gut flora. Ulcerative colitis treatment typically involves anti-inflammatory medications, immunomodulators, or biologics, as outlined in the AGA clinical practice guidelines 1. The guidelines suggest using infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, or ustekinumab for moderate to severe ulcerative colitis, with a strong recommendation for their use over no treatment.

Some key points to consider in the treatment of ulcerative colitis include:

  • The use of biologic agents, such as infliximab or vedolizumab, for induction of remission in adult outpatients with moderate to severe ulcerative colitis 1
  • The suggestion against using thiopurine monotherapy for induction of remission, and the recommendation for using thiopurine monotherapy for maintenance of remission in patients with moderate to severe ulcerative colitis 1
  • The importance of early use of biologic agents with or without immunomodulator therapy, rather than gradual step-up after failure of 5-aminosalicylates 1

In contrast, the use of azithromycin in ulcerative colitis is not supported by strong evidence, and its use may be associated with potential risks, such as disrupting gut flora. A study on the use of antibiotics in Crohn's disease found that azithromycin was effective in achieving remission in some patients, but the evidence was not strong enough to support its use as a first-line treatment 2.

Overall, the treatment of ulcerative colitis should be guided by the AGA clinical practice guidelines, which recommend the use of anti-inflammatory medications, immunomodulators, or biologics, rather than antibiotics like azithromycin. The potential benefits of using azithromycin in ulcerative colitis do not outweigh the potential risks, and its use is not recommended.

From the Research

Treatment of Ulcerative Colitis with Azithromycin

  • There is limited evidence to support the use of azithromycin in the treatment of ulcerative colitis 3, 4.
  • Azithromycin has been studied for its potential use against gastroenteritis-causing pathogens, but its effectiveness in treating ulcerative colitis is not well established 5.
  • The use of antibiotics in ulcerative colitis is generally not recommended, except in cases of severe colitis or infectious complications 3, 4, 6.
  • Other antibiotics, such as ciprofloxacin, metronidazole, and rifaximin, have been studied for their potential use in treating ulcerative colitis, but the evidence is limited and inconsistent 3, 4.
  • The treatment of ulcerative colitis typically involves the use of aminosalicylates, corticosteroids, and immunosuppressants, rather than antibiotics 3, 4, 6.

Role of Azithromycin in Inflammatory Bowel Disease

  • Azithromycin may have a role in reducing the recurrence of postoperative Crohn's disease when used in combination with azathioprine 6.
  • However, the use of antibiotics in inflammatory bowel disease is limited by the risk of side effects, including Clostridium difficile infection 7, 6.
  • More research is needed to fully understand the potential benefits and risks of using azithromycin in the treatment of inflammatory bowel disease, including ulcerative colitis 3, 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.